Numeric Investors’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$7.28M Buy
212,976
+40,000
+23% +$1.28M 0.05% 340
2017
Q3
$5.55M Buy
172,976
+82,977
+92% +$2.62M 0.04% 378
2017
Q2
$2.93M Buy
89,999
+31,423
+54% +$995K 0.03% 435
2017
Q1
$1.84M Buy
58,576
+41,476
+243% +$1.23M 0.02% 500
2016
Q4
$503K Sell
17,100
-97,084
-85% -$2.96M ﹤0.01% 829
2016
Q3
$3.3M Buy
+114,184
New +$3.18M 0.03% 384
2016
Q2
Sell
-113,899
Closed -$2.82M 1236
2016
Q1
$2.82M Buy
+113,899
New +$3.13M 0.03% 378

Other funds holding GHDX

Numeric Investors's GHDX Position: Q4 2017 in Review

Numeric Investors increased its Genomic Health, Inc. (GHDX) stake by 23% in Q4 2017, buying an estimated $1.28M and bringing the position to 212,976 shares worth $7.28M. The position accounts for 0.05% of the portfolio, ranked #340.

Numeric Investors first reported a position in GHDX in Q1 2016 and has held it in 7 quarters since. 135 funds tracked by Wall St. Rank hold GHDX as of Q4 2017.

  • Numeric Investors held 212,976 shares of Genomic Health, Inc. worth $7.28M as of Q4 2017.
  • Numeric Investors bought 40,000 Genomic Health, Inc. shares in Q4 2017, an estimated $1.28M.
  • Genomic Health, Inc. made up 0.05% of Numeric Investors's portfolio in Q4 2017, its #340 holding.
  • Numeric Investors first reported a position in Genomic Health, Inc. in Q1 2016 and has held it in 7 quarters since.
  • 135 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.